Kenzo Ohara

Intratumoral administration of cGAMP transiently accumulates potent macrophages for anti-tumor immunity at a mouse tumor site

Takayuki Ohkuri, Akemi Kosaka, Kei Ishibashi et al. · Cancer Immunology Immunotherapy · 2017 · 210 citations · Full text

Life Sciences, Immunology, Oncology +16

Programmed death-ligand 1 and its soluble form are highly expressed in nasal natural killer/T-cell lymphoma: a potential rationale for immunotherapy

Toshihiro Nagato, Takayuki Ohkuri, Kenzo Ohara et al. · Cancer Immunology Immunotherapy · 2017 · 162 citations · Full text

Life Sciences, Immunology, Oncology +16

CD47 blockade enhances the efficacy of intratumoral STING-targeting therapy by activating phagocytes

Akemi Kosaka, Kei Ishibashi, Toshihiro Nagato et al. · The Journal of Experimental Medicine · 2021 · 55 citations · Full text

Medicine, Immunology, Oncology +17

Epigenetic modification augments the immunogenicity of human leukocyte antigen G serving as a tumor antigen for T cell-based immunotherapy

Kei Ishibashi, Takumi Kumai, Takayuki Ohkuri et al. · OncoImmunology · 2016 · 34 citations · Full text

Life Sciences, Immunology, Oncology +17

Immunomodulation via FGFR inhibition augments FGFR1 targeting T-cell based antitumor immunotherapy for head and neck squamous cell carcinoma

Michihisa Kono, Hiroki Komatsuda, Hidekiyo Yamaki et al. · OncoImmunology · 2022 · 34 citations · Full text

Life Sciences, Immunology, Oncology +17